Total Payments
$2,034
2024 Payments
$565.57
Companies
35
Transactions
118
Medicare Patients
36,052
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$2,029 (99.7%)
Education$5.38 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,029 | 116 | 99.7% |
| Education | $5.38 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $374.40 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $214.64 | 12 | $0 (2024) |
| PFIZER INC. | $195.56 | 8 | $0 (2023) |
| ABBVIE INC. | $186.96 | 11 | $0 (2023) |
| Amgen Inc. | $113.54 | 8 | $0 (2024) |
| Exact Sciences Corporation | $97.86 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $78.40 | 6 | $0 (2024) |
| Novo Nordisk Inc | $71.52 | 5 | $0 (2024) |
| Allergan Inc. | $59.91 | 4 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $49.40 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $565.57 | 27 | Daiichi Sankyo Inc. ($155.85) |
| 2023 | $561.59 | 32 | ABBVIE INC. ($110.31) |
| 2022 | $361.81 | 23 | Daiichi Sankyo Inc. ($93.57) |
| 2021 | $136.94 | 10 | Novo Nordisk Inc ($55.13) |
| 2020 | $95.28 | 1 | PFIZER INC. ($95.28) |
| 2019 | $50.27 | 4 | PFIZER INC. ($37.25) |
| 2018 | $80.62 | 6 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($29.90) |
| 2017 | $181.89 | 15 | AbbVie, Inc. ($62.38) |
All Payment Transactions
118 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Pulmonology | ||||||
| 11/08/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $30.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.08 | General |
| 09/13/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Inflammation | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: DIABETES | ||||||
| 08/15/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: VACCINE | ||||||
| 07/30/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: DIABETES | ||||||
| 06/26/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Oncology | ||||||
| 05/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Bone Health | ||||||
| 04/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Inflammation | ||||||
| 04/10/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $35.72 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/27/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.39 | General |
| 03/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.36 | General |
| 02/20/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 71 | 7,534 | 15,134 | $1.2M | $355,609 |
| 2022 | 77 | 8,034 | 15,763 | $1.3M | $365,478 |
| 2021 | 84 | 9,629 | 20,167 | $1.5M | $412,088 |
| 2020 | 88 | 10,855 | 21,844 | $1.5M | $405,542 |
Total Patients
36,052
Total Services
72,908
Medicare Billing
$1.5M
Procedure Codes
320
All Medicare Procedures & Services
320 procedure records from CMS Medicare Utilization — Page 1 of 13
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 876 | 1,537 | $301,252 | $123,995 | 41.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 25 | 2,040 | $61,380 | $37,768 | 61.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 325 | 429 | $57,915 | $25,513 | 44.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 249 | 252 | $31,500 | $18,989 | 60.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 75 | 89 | $35,600 | $13,483 | 37.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 817 | 1,296 | $25,920 | $10,870 | 41.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 504 | 550 | $49,500 | $9,003 | 18.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 642 | 664 | $63,080 | $8,664 | 13.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 744 | 822 | $63,294 | $8,458 | 13.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 67 | 67 | $14,070 | $8,374 | 59.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 34 | 36 | $20,700 | $7,675 | 37.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 256 | 261 | $9,657 | $7,613 | 78.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 23 | 23 | $40,710 | $6,293 | 15.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 44 | $11,440 | $5,761 | 50.4% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 687 | 748 | $29,920 | $4,717 | 15.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $8,448 | $4,224 | 50.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 23 | 46 | $8,050 | $4,059 | 50.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 233 | 407 | $26,455 | $3,869 | 14.6% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 188 | 188 | $18,612 | $3,557 | 19.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 39 | 39 | $23,595 | $3,341 | 14.2% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 19 | 19 | $38,950 | $2,835 | 7.3% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 19 | 19 | $4,750 | $2,717 | 57.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 69 | 69 | $25,875 | $2,504 | 9.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 186 | 236 | $13,924 | $1,951 | 14.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 49 | 204 | $8,160 | $1,913 | 23.4% |
About Dr. David Hipp, MD
Dr. David Hipp, MD is a Internal Medicine healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396789152.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hipp, MD has received a total of $2,034 in payments from pharmaceutical and medical device companies, with $565.57 received in 2024. These payments were reported across 118 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($2,029).
As a Medicare-enrolled provider, Hipp has provided services to 36,052 Medicare beneficiaries, totaling 72,908 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 320 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Pinehurst, NC
- Active Since 06/15/2006
- Last Updated 01/24/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1396789152
Products in Payments
- INJECTAFER (Drug) $374.40
- JARDIANCE (Drug) $115.84
- VRAYLAR (Drug) $108.17
- Cologuard Collection Kit (Device) $97.86
- ELIQUIS (Drug) $95.28
- Otezla (Drug) $70.86
- SHINGRIX (Biological) $66.18
- TZIELD (Biological) $49.40
- PREVNAR 20 (Biological) $47.63
- Androgel (Drug) $47.26
- Kerendia (Drug) $45.02
- EVENITY (Biological) $42.68
- NAMZARIC (Drug) $37.36
- CHANTIX (Drug) $37.25
- QUVIVIQ (Drug) $36.27
- QUTENZA (Drug) $35.72
- PreHevbrio (Drug) $33.23
- Ozempic (Drug) $31.23
- Tymlos (Drug) $31.11
- Impella (Device) $30.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pinehurst
Michael Soboeiro, Md, MD
Internal Medicine — Payments: $428,147
Internal Medicine $428,147
Sun Moon Kim, M.d, M.D
Internal Medicine — Payments: $32,753
Internal Medicine $32,753
Joan Maradey, Md, MD
Internal Medicine — Payments: $11,388
Internal Medicine $11,388
Brandon Williams, Md, MD
Internal Medicine — Payments: $7,695
Internal Medicine $7,695
Farra Wilson, D.o, D.O
Internal Medicine — Payments: $5,711
Internal Medicine $5,711
Alex Bonnecaze
Internal Medicine — Payments: $4,702
Internal Medicine $4,702